Trial · NCT01071200
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Dose of Follicular Stimulating Hormone (FSH) for Retrieved Oocytes | Baseline (Stimulation day 8 [S8]) until hCG day | |
| Secondary | Mean Total Follicle Stimulating Hormone (FSH) and Recombinant Human Luteinizing Hormone (r-hLH) Dose | Baseline (S8) until hCG day | |
| Secondary | Mean Number of Ovarian Stimulation Days | Baseline (S8) until hCG day | |
| Secondary | Change From Baseline in Oestradiol (E2) Levels at Human Choriogonadotropin (hCG) Day | Baseline (S8) and hCG day | |
| Secondary | Mean Total Number of Retrieved Oocytes | 34-36 hours post-hCG (OPU) | Mean number of oocytes retrieved on the day of ovum pick up (OPU) was counted. Oocyte retrieval is a technique used in in-vitro fertilization in order to remove oocytes from the ovary of the female, enabling fertilization outside the body. |
| Secondary | Mean Number of Mature Oocytes (Metaphase II) | 34-36 hours post-hCG (OPU) | Mean number of metaphase II oocytes was counted for participants undergoing ovum pick up for IntraCytoplasmic Sperm Injection (ICSI). ICSI is a procedure in which a single spermatozoon is injected into the oocyte cytoplasm. Metaphase II stage of the oocyte was classified as the time at which the first polar body was observed microscopically. Metaphase II oocytes are a sub-group of the total number of oocytes. |
| Secondary | Fertilization Rate | 12-18 day post-hCG and/or Week 7 | Fertilization rate was measured as the ratio between number of fertilized oocytes and number of inseminated oocytes (maximum 3). |
| Secondary | Number of Obtained Embryos | Day 3 post-hCG (Embryo transfer [ET]) | Total number of obtained embryos with maximum 3 inseminated oocytes was calculated. |
| Secondary | Number of Transferred Embryos | Day 3 post-hCG (ET) | Embryo transfer is the procedure in which one or more embryos are placed in the uterus or Fallopian tube. |
| Secondary | Percentage of Participants With Pregnancy | 12-18 day post-hCG and/or Week 7 | |
| Secondary | Percentage of Participants With Clinical Pregnancy | 12-18 day post-hCG and/or Week 7 | Clinical pregnancy is defined as pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or definitive clinical signs of pregnancy. It includes ectopic pregnancy. |
| Secondary | Percentage of Participants With Implantation | 12-18 day post-hCG and/or Week 7 | Implantation is the attachment and subsequent penetration by the zona-free blastocyst (usually in the endometrium) that starts five to seven days after fertilization. |
| Secondary | Number of Participants With Ovarian Hyper Stimulation Syndrome (OHSS) | Baseline (S8) until 12-18 day post-hCG and/or Week 7 | OHSS is an exaggerated systemic response to ovarian stimulation characterized by a wide spectrum of clinical and laboratory manifestations. It is classified as mild, moderate or severe according to the degree of abdominal distention, ovarian enlargement and respiratory, haemodynamic and metabolic complications. |
| Secondary | Number of Cycles Cancelled Due to Risk of OHSS | Baseline (S8) until 12-18 day post-hCG and/or Week 7 | OHSS is an exaggerated systemic response to ovarian stimulation characterized by a wide spectrum of clinical and laboratory manifestations. It is classified as mild, moderate or severe according to the degree of abdominal distention, ovarian enlargement and respiratory, haemodynamic and metabolic complications. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01071200/registered